Walgreens caps buyout of infusion pharmacy
DEERFIELD, Ill. Walgreen Co. has completed its acquisition of CuraScript Infusion Pharmacy, a wholly owned subsidiary of Express Scripts. The acquired home infusion specialty firm will be merged with Walgreens’ expanding specialty pharmacy operations under Option Care Enterprises, a subsidiary.
Based in Louisville, Ky., CuraScript is in its 17th year providing home infusion services for patients who require complex therapies including anti-viral, immune deficiency, inotropic, chemotherapy and pain management treatments. Walgreens acquired each of CuraScript Infusion Pharmacy’s 12 facilities located in Alabama, Indiana, Kentucky, Missouri, Ohio and Tennessee.
“This acquisition further expands our national coverage in home infusion services,” said Paul Mastrapa, president of Walgreens-OptionCare. “We now operate more than 100 home infusion locations in 35 states. CuraScript Infusion Pharmacy is highly regarded in the industry for its clinical expertise and commitment to exceptional patient care.”
Terms of the acquisition were not disclosed, but Walgreens did reveal that Express Scripts will retain ownership of CuraScript Specialty Pharmacy and CuraScript Specialty Distribution.
TeleManager introduces central IVR system
NEWARK, N.J. TeleManager Technologies will unveil its new Central Interactive Voice Response system at the 2008 National Association of Chain Drug Stores Pharmacy and Technology Conference.
The new system will allow callers to speak their responses into the IVR templated system meaning that, callers can request refills by product name rather than needing to know and key in their prescription number.
The system will also be set-up as a centralized, Windows-based configuration, which will eliminate expensive hardware that would’ve been needed at each individual pharmacy. This will allow the IVR to either be set-up at a pharmacy’s headquarters or TeleManager could host all the functions and then forward the information to the right location.
Additional new features include extensive outbound calling, surveying and marketing functionality. Outbound Refill Reminder and Will-Call Bin pick-up reminder calls will help to improve compliance and improve pharmacy efficiencies. Also, new targeted messaging capabilities can be used to provide specific information to any subset of patients (e.g., first time patients, opt-in customers, specific therapeutic category users, etc.). Likewise, HIPAA compliant opt-in calls allow the pharmacy (centrally or store controlled) to contact segments of its customer base for special services and offers.
FDA approves Animas’ glucose management system
WEST CHESTER, Pa. The Food and Drug Administration has approved Animas’ OneTouch Ping Glucose Management System, Animas announced Tuesday.
The OneTouch Ping uses wireless technology to communicate with a blood-glucose meter-remote. The meter-remote allows patients to calculate insulin doses and instruct the pump to deliver them without touching the pump itself.
OneTouch Ping also works with ezManager MAX Diabetes Management software, which allows users to upload information from the meter-remote and insulin pump to a Mac or PC.
“OneTouch Ping provides patients the advanced insulin pump technology from Animas plus the OneTouch blood glucose technology they trust, put together into a system that offers the discretion, convenience and option of remote insulin dosing,” said Dr. Juan Frias, Animas’ chief medical officer and vice president of medical affairs.
Animas is a division of Johnson & Johnson.